RRM2 and pancreatic neoplasm: Consistently, earlier studies have implicated a causal relationship between let-7 and RRM2, identifying downregulation of many let-7 family members in RRM2-overexpressing, gemcitabine-resistant pancreatic cancer cells or a reduction in RRM2 expression after let-7 overexpression [17], [18].